Accepted for publication 9th June, 1995. There are many possible reasons for administering premedication, but the main one is to relieve fear and anxiety. 1-3 Other possible reasons are sedation, amnesia, analgesia, parasympatholytic, effect and decrease of salivation. From the patient's point of view, what matters is safety and that they experience as pleasant a visit to the operation unit as possible. It is well known that the preoperative visit of an anaesthetist has a calming effect. I; Benzodiazepines are the most popular premedicants for pharmacological sedation and anxiolysis because of their minimal side effects.~ Of the newer CAN J ANAESTH 1995 / 42:10 / pp 862-8
I0 mg po, that it is suitable for patients that cannot swallow, and that the patients were more satisfied with it than with diazepam.

Au cours d'une ~tude aMatoire et ~ double insu, le triazolam (T) sublingual 0,2 mg est compard en prdmddication au diazdpam (19) oral 10 mg. Quatre-vingt-un patients ASA I-III ages de 18 ~ 70 ans programmds pour une chirurgie non urgente sous anesth~sie g$n~rale font pattie de l~tude. Les patients sont pt~mddiqu~s environ une heure avant l~ntervention. Les sujets du groupe T (n = 41) refoivent le triazolam sl apr~s un placebo po et les sujets du groupe D (n = 40) le diaz~pam po avant le placebo sL L'anxi~t~ et la s~dation sont ~valu~es avant la prdm~dication et aux 15 rain par la suite jusqu'au d@art du patient vers la salle d'opdration, immddiatement avant l'induction de l'anesth~sie ainsi clue 30 et 60 rain apr~s l~ntervention. L'anxidt~ et la s~dation sont ~valu~es par la patient sur une dchelle visuelle analogue (EVA) et par I'anesth~siste sur une dchelle 0-3 pour l'anxi~t~ et 0-4 pour la s~dation. L'expdrience du patient au regard de sa pr$m~dication et de son s~jour en salle d'op~ration est ~valu~e apr~s l~ntervention. La s~dation et l'anxiolyse ne deviennent apparentes dans les deux groupes que 30 ~ 45 rain aprks la pr~m~dication, mais immkdiatement avant l~nduction, L'anxiolyse et la sddation ne sont manifestes que dans le groupe T. On ne retrouve pas de difference entre les groupes en aucun moment. Les patients du groupe T se disent plus satisfaits de leur pr$rr~dication et de leur s$jour en salle d'opdration. Aucun des patients des deux groupes n'a pr~sent~ d'effets secondaires cardiorespiratoires ou autres. On condut que le triazolam 0,2 mg sl est au moins aussi efficace en pr$m~dication que le diazdpam 10 mg po, qu fl est appropri~ pour ceux qui ne peuvent avaler, et qu'il satisfait plus le patient que le diazdpam.
benzodiazepines, triazolam has been widely used for night sedation. 4 There are some studies with conflicting results on the use of orally administered triazolam as a premedicant for day-case surgery. 4 
-H
A new form of sublingual triazolam has recently been presented. The bioavailability of this sl form is 28% better than for po triazolam. The time to peak plasma concentration (1.22 hr) and the elimination half-life (4.1 hr) are similar to po triazolam tz and are shorter than for diazepam. The sl route of administration has some advantages over the po route. It is not always possible for the patient to take an oral premedicant (occlusion of GItract etc.), or in some situations the bioavailability of the medicine is decreased or delayed (vomiting patient).
To our knowledge there are two studies on sl triazolam. 8.13 That of Kontinen et al. 13 was an evaluation of sedation and anxiolysis as a function of lime and they found better sedation with triazolam, but no difference in anxiolysis between triazolam and diazepam.
The purpose of this study was to compare the effect of triazolam sl as a premedicant with diazepam po in healthy adult patients undergoing surgery and general anaesthesia.
Methods
Premedication and anaesthesia
Eighty-one ASA I-III patients, between the ages of 18 and 70 yr presenting for elective surgery and general anaesthesia were admitted to the study after informed consent. Exclusion criteria were pregnancy, breastfeeding, allergy to benzodiazepines, myasthenia gravis and chronic use of hypnotics or sedatives. The trial was approved by the Ethical Committee of the Oulu University Hospital.
Premedication was randomised into two groups in blocks of ten. Doubleblinding was carried out with a placebo: every patient received a tablet to swallow and a s/resoriblet, of which one was a placebo. In the triazolam group (n = 41), patients received triazolam 0.2 mg sl after a placebo po, and in the diazepam group (n = 40) diazepam 10 mgpo before a placebo sl.
Anaesthesia was induced with fentanyl 0.1-0.15 mg and thiopentone 4-5 rag. kg -I and was maintained after tracheal intubation with 70% N20 in oxygen, fentanyl 0.05-0.I mg. 30-60 rain -! and enflurane or isoflurane ad 1% if needed. Muscle relaxation was achieved with alcuronium 0.2-0.3 mg-kg -I initially and 0.05 rag-kg -1 subsequently if needed. At the end of the operation muscle relaxation was reversed with a mixture of neostigmine 2.5 mg and glycopyrrolate 0.2 mg and the tracheas were extubated. The patients were followed up in the recovery room as per the normal hospital routine.
Evaluations
Blood pressure and heart rate were registered the day before the operation, and the anaesthetist evaluated patients' anxiety. Sedation and anxiety were evaluated and blood pressure, heart rate and percutaneous oxygen saturation were measured in the recovery room just before premedication, and at 15, 20, 30, 45, 60, 75 and 90 min after that until the patient was taken to the operating room where the same evaluations were carded out just before the induction of anaesthesia, and in the recovery room 30 and 60 rain after the operation. The anaesthetist evaluated sedation on a scale of 0-4:0 = fully awake, 1 = slightly drowsy, 2 = asleep, but easily arousable, 3 = fully asleep, but arousable and 4 = fully asleep, not arousable. Anxiety was evaluated by the same anaesthetist on a scale of 0-3:0 = relaxed, 1 = minor, 2 = moderate and 3 = severe anxiety. A visual analogue scale (VAS) was used for the patients to evaluate their sedation and anxiety. The VAS scale was a red-white, linear, 50 cm long and 10 cm high card, on which the patients pointed to the grade of their sedation and the degree of anxiety that they were experiencing. The extremes were "no sedation or anxiety" (left, white end with zero points) and "so deep a sedation that one cannot stay awake or anxiety as bad as one can imagine" (fight, red end with 50 points). The eentimetre scale was on the back of the card. Both the adjective scale and the visual analogue scale were the same as that used in the study of Kontinen et al. 13 (Figure 1) .
A Cardiocap| (Datex, Helsinki, Finland) monitor was used to measure percutaneous oxygen saturation (SpO2), blood pressure and heart rate. Heart rate was measured by monitoring ECG and blood pressure was measured non-invasively from the left arm. The SpO2 was measured with a finger probe on the left middle finger. The time from premedication to the induction of anaesthesia and operation time were recorded. For the extubation time, the lime from the injection of the neostigmineglycopyrrolate combination to extubation was recorded for the final 31 patients. The length of stay in the recovery room was recorded for all patients. Patients who stayed overnight in the recovery room due to the type of operation, were excluded. The patients' opinions on their visit to the operating room were recorded one hour after the operation and the next day by the anaesthetist and when or after leaving the hospital with a questionnaire. The alternatives were total amnesia, very pleasant, pleasant, satisfactory and unpleasant. On the second day and when leaving the hospital patients were also questioned about their premedication: "Was the premedication excellent, good, satisfactory, poor" and: "If needed would they prefer the same, a stronger or a weaker premedication in future."
The visual analogue scale 0/AS) was a red-white, linear, 50 era long and I0 em high card with a eentimetre scale on the reverse side.
Statistics
Differences in repeated measures were examined for statistical significance using ANOVA of repeated measures with post-hoe Sheffe's test. Differences in related characteristics between the study groups were examined for statistical significance using ehi-square test for discrete variables and t test for continuous variables. A two-way analysis of variance was used to test the difference in the assessments between the observers. All tests of signiticancc were two-tailed, a P-value of 0.05 was accepted as the limit of signitieance.
R e s u l t s
The two groups of patients were comparable with respect to sex, age, height, weight, body mass index and ASAstatus. The nature of the operation was also comparable in the groups (Table I) .
After premedieation, the systemic mean arterial pressure (MAP) and heart rate (HR) decreased similarly in both groups. The mean MAP starting value was 99 4-13 mmHg in both groups and HR 74 4-13 bpm in the triazolam group and 74 :t: 12 in the diazepam group. In the period before operation the lowest MAP and HR values were measured at 90 min after premeditation and were 82 4-12 mmHg and 63 4-10 bpm in the triazolam group and 86 4-6 mmHg and 63 4-7 bpm in the diazepam group respectively. At induction of anaesthesia the mean values of MAP and HR were 97 + 14 mmHg and 75 + 15 bpm in the triazolam group and in the diazepam group the values were 99 4-14 mmHg and 74 4-12 bpm, respectively. Postoperatively, the lowest MAP and HR were 87 4-15 mmHg and 70 4-14 bpm in the triazolam group and 89 4-12 mmHg and 69 + 14 bpm in the diazepam group. The mean starting value of oxygen saturation (SpO2) in the triazolam group was 98 4-1% and 97 4-I% in the diazepam group. The lowest single measurements of SpO2 were 93% in the triazolam group and 91% in the diazepam group prior to the operation and 90% in both the groups postoperatively. All patients in both groups were arousable at all times.
In the diazepam group the study was interrupted in one subject for 30 min because of a headache so intense 
Sedation and anxiety
There were no differences between the groups in degree of sedation before premedication or after that at any time.
The number of patients in both groups decreased as a function of time after premedication, as they were taken to the operating room as soon as possible. Thus, the groups after premedication were examined for statistical significance only until 45 rnin, because after that the groups were too small to use ANOVA. Sedation was zero (no sedation at all) in all patients in both groups before premeditation as evaluated by the anaesthetist. The mean starting values for sedation as evaluated by the patients using the VAS (scale 0-50) were 14.7 + 9.8 in the triazolam group and 10.9 4-10.8 in the diazepam group. According to the anaesthetist's evaluation, sedation became significant at 45 min after premeditation (P < 0.001 in the triazolam group and P = 0.009 in diazepam group) as well as postoperatively (P < 0.001 in both groups) with respect to the starting values ( Figure 2) . Just before the induction of anaesthesia in the operating room the anaesthetist evaluated sedation as 0.59 4-0.71 in the triazolam group and 0.45 4-0.64 in the diazepam group. At that time sedation was not different from the starting value for either group (Table II) . According to the patients' evaluation, sedation reached was different from control at 30 and 45 rain atter premedication in the diazepam group (P = 0.008 and 0.003) Sed. and Anx. obs. = the observer's evaluation of sedation (scale 0-4) and anxiety (saele 0-3). Sed. and Anx. VAS = the sedation and anxiety evaluations by the patients using a 50 cm long, red and white visual analogue scale (mean, SD). There was no statistical signitieanee between the groups and the P-values reflect the significance of sedation and anxiolysis with respect to the starting values.
was different only from the starting values in the triazolam group (P < 0.001) (Table II) . There was no difference in anxiety between the groups the evening before the operation, just before premeditation or at any time alter premeditation and operation.
The mean values of anxiety just before premedieation in the anaesthetist's evaluations were 0.88 -1-0.75 in the triazolam group and 0.73 -t-0.72 in the diazepam group and the VAS values were 14.7 -4-9.8 and 10.9 4-10.8, respectively. After premedieation, anxiolysis was different from control, according to the evaluation of the anaesthetist, in the triazolam group only at 30 and 45 min (P = 0.02 and P < 0.001) with respect to the starting value. Also postoperatively there was significant anxiolysis in the triazolam group only (P < 0.001) ( Figure  3 ). In the operating room just before the induction of anaesthesia, anxiety was evaluated by the anaesthetist as 0.12 4-0.40 in the triazolam group and 0.25 -t-0.65 in the diazepam group and there was significant anxiolysis only in the triazolam group (P = 0.004) (Table II) .
Anxiolysis evaluated by the patients after premeditation was different from starting values at 30 and 45 min in the triazolam group (P = 0.01 and P < 0.001) and at 45 rain in the diazepam group (P = 0.04). Postoperatively anxiolysis was significant in both groups (P < 0.001) (Figure 3 ). Before the induction of anaesthesia, anxiety was evaluated by the patients as 8.4 -I-11.7 in the triazolam group and 10.5 4-13.2 in the diazepam group and was statistically significant in the triazolam group only (P = 0.002) (Table II) .
and at 45 min in the triazolam group (P < 0.001). Postoperatively, sedation was different from control in both groups (P < 0.001) (Figure 2 ). Before anaesthesia induction in the operating room, sedation was 27.5 -I-13.9 in the triazolam group and 21.9 + 14.7 in the diazepam group according to the patients' own evaluation and
Other measurements
There was no difference between the groups during anaesthesia as to anaesthesia requirements, but fewer patients needed oxicodon postoperatively with or without didofenae (P = 0.015) in the triazolam group. In our hospital, anaesthesia nurses control the administration of oxicodon by the orders of anaesthetists and it usually is given when a patient claims pain or is otherwise agitated. At the end of anaesthesia the time to extubation for the patients in the triazolam group was longer (P = 0.04), but there was no difference between the groups as to their stay in the recovery room (Table III) . The extubation time was recorded from the injection of neostigmineglycopyrrolate combination at the end of surgery to the extubation of trachea. The ward time of a routine patient in the recovery room was determined by the anaesthesia nurses in the usual manner of our hospital, by clinically evaluating if the patient was recovered enough to be taken care of on a ward.
Patients" opinions
The patients' opinions of their premedieation and visit to the operating room were obtained three times and the results were similar each time. Seventy-eight of 81 patients (96%) answered the questionnaire and we only present those results. Eight patients (21%) in the triazolam group and one (3%) in the diazepam group had total amnesia concerning their visit to the operating room. Of those patients without total amnesia, triazolarn patients were more pleased with their Visit (P = 0.026) and liked their medication better (P = 0.017). In the triazolam group, 21% of the patients experienced their visit to the operative unit as very pleasant and 8% in the diazepam group. The visit was unpleasant for 3% and 10% of the patients, respectively. The effect of the premedication was excellent in 36% of the patients in the triazolam group and 8% of the diazepam group. The effect was poor in 3% and 8% of the patients, respectively. In spite of this, most patients in both groups would prefer to have the same premedication in future if needed (Figure 4 ).
Discussion
Triazolam has been widely studied in earlier reports as an overnight sedative and there are some studies on tri-
The patients' opinion of their visit to the operative unit (upper Figure) and the effect of their premedieation (lower Figure) was evaluated when or al~er leaving the hospital. The patients in tile triazolam group were more satisfied with their visit (P = 0.026) and their premedication (P = 0.017).
azolam as a po premedicant. The results of these studies are somewhat conflicting, especially with respect to anxiolysis. 4-H As far we know there are only two studies of sl triazolam for premedication. One study was carried out in outpatients undergoing minor surgery s and the other in elderly patients undergoing ophthalmic operations under local anaesthesia, t3 Because of the difference in bioavailability, a sl dose of 0.20 mg is considered to correspond to a dose of 0.25 mg po (sl triazolam registration documentation), and triazolam 0.25 mg po has been regarded as comparable to a I0 mg dose of diazepam. 4,6,9:3 In this study, the aim was to compare tfiazolam 0.20 mg sl to diazepam 10 mg po. Instead of relating the benzodiazepine dose to body weight the commercially available preparations were used, as this more closely approximates actual clinical situations. A placebo group was not included because the placebo effect has been recorded in earlier studies. 4,6,9,1~ Apart from the study by Kontinen et al., 13 there has been only one assessment of sedation and anxiolysis at a fixed ILrne in earlier studies, so the onset of action and maximum effect may have been missed. In this study, as in that of Kontinen et ai., the parameters were tested in the patients as a function of time. At 45 min after premedieation the number of the subjects in the test groups began to diminish, because the patients were removed to the operating rooms as soon as they became available.
There were no differences in sedation and anxiolysis between the groups before or after premeditation at any time. Sedation and anxiolysis became significant in both groups with respect to the starting values almost equally at 30-45 min after premedication. The statistical significance was examined using ANOVA of repeated measures with a post hoc Sheffe's test and 60 rain after premedication the numbers of the subjects in the groups were so small that it was not possible to include the period from 60 to 90 min after premeditation in the statistical calculations. Thus, this study shows no statistically significant sedation or anxiolysis at that time. The most important task for premeditation is to cause sedation and anxiolysis at the time when the patient enters the operating room and is prepared for the induction of anaesthesia and operation. In our study, only triazolam caused significant anxiolysis and sedation at that time. There is no difference in sedation or anxiolysis with diazepam patients at that time by any of the evaluations. In both groups sedation and anxiolysis were significant postoperatively with respect to the starting values and thus the end point of sedation and anxiolysis could not be determined in this study. The final measurements postoperatively were performed at a mean of four hours after premedication. Obviously, general anaesthesia affected the postoperative results because we used long-acting anaesthetics and the anaesthesias and operations were rather long in duration. This result does not conflict with earlier studies and confirms the earlier results that triazolam is not recommendable for day-care surgery 6,13 The fact that there was no difference between the groups may be explained by a similar effect of the drugs under study, by groups too small for adequate analysis or by the fact that the statistical observation period (ad. 45 min after premedieation) was too short for any difference to appear. Results have been conflicting in earlier studies especially with respect to anxiolysis, which is a subjective feeling and therefore difficult to evaluate. Some investigators have found triazolam to have an excellent anxiolytic property and some have found no anxiolysis with triazolam. This study shows triazolam to be at least as anxiolytic and sedative as diazepam. Both the observer's evaluations and the use of a visual analogue scale has been criticised in that it is possible to confuse sedation with anxiolysis. 3-H,~3 The conflicting results may also be due to different kinds of patients and/or operations. In this study, the starting value of anxiety was low and it is obvious that no considerable degree of anxiolysis can be achieved when the anxiety level is low to start with.
The requirements for anaesthetics during surgery were similar, but in the triazolam group, tracheas were extubated more slowly at the end of anaesthesia, which may indicate a deeper level of sedation caused by the premeditation. Even if there was no statistically significant difference in sedation or anxiety between the groups the need for analgesia, oxicodon, was lower in the tri azolam group. That may indirectly indicate greater postoperative sedation in the triazolam group because our anaesthesia nurses in the recovery room also administer oxicodon also for agitation. There was no statistically signiticant difference in the stay in the recovery room.
The patients' opinions of their overall visit to the operative unit, the efficacy of the premeditation and the next premeditation if needed were examined three times. The results of the three evaluations were almost equal: the triazolam patients were more pleased with their premedication and visit to the operative unit. The patients' opinions were similar to those in an earlier study by Forrest et al., which surprised them, as their own results for anxiolysis did not favour triazolam. 6 Eight patients were amnestic in the triazolarn group and only one in the diazepam group. This is an important result, even if in our study amnesia was not tested in detail. The patients were only asked to evaluation their visit to the operating room and one of the alternatives was not remembering anything. None of the amnestic patients spontaneously reported any dissatisfaction with their amnesia.
There were no adverse cardiorespiratory reactions, nor did we observe any of the untoward behavioural effects which have been described earlier after triazolam administration (angry outbursts, assaultiveness, depersonalisation, depression, suicidal ideation, agitated psychosis, confusion, delirium, nightmares, and hallucinations). J4,1s After premeditation, one patient in the diazepam group suffered an intense headache so that the study had to be interrupted for half an hour. After the administration of 50 mg of diclofenac/v she was able to continue the study.
In summary, we feel that as a premedicant for general anaesthesia, triazolarn 0.20 sl is as safe and at least as potent a sedative and anxiolytic as diazepam 10 mg po, and that the patients were more satisfied with triazolam. It is also a very convenient way to premeditate patients who can not be premedicated po.
